Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
Year: 2017
Type: review
Source: Cancer Treatment Reviews
Institution: Weill Cornell Medicine
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: metastatic castration-resistant prostate cancer, treatment resistance, androgen receptor-targeted therapy, taxane-based chemotherapy, docetaxel, cabazitaxel, abiraterone, enzalutamide, TMPRSS2-ERG fusion, multidrug resistance, epithelial-mesenchymal transition, treatment sequencing, resistance biomarkers
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W2613775504
